P552 Gastroenterologists’ perceptions on use of medical cannabis for IBD
B. Koslowsky*1, A. Bar-Gil Shitrit1, E. Goldin1, B. Mazuz1
1Shaare-Zedek Medical Center, Digestive Diseases Institute, Jerusalem, Israel
The use of medical cannabis (MC) for numerous medical indications is expanding. Current evidence does not support the efficacy of MC for reducing inflammation in IBD patients. Even so, many gastroenterologists encounter the issue of recommending use of MC to IBD patients.
A computerised survey was conducted to 250 gastroenterologists in Israel. 84 (34%) physicians completed the questionnaire.
Out of 84 physicians whom completed the questionnaire, 59 (70%) were male, 34 (40%) were under age 50, 71 (85%) were adult gastroenterologists, and 53 (63%) work mainly in a hospital. Forty-four per cent, 41% and 15% of physicians think that MC is very effective, mildly effective and not effective at all, respectively. Physicians will commonly, rarely and never recommend MC in 42%, 35% and 22%, respectively. Older physicians (above age 50) were significantly more likely to have a positive attitude towards MC in both questions,
The use of MC for IBD patients is encountered by many IBD physicians. Different doctors hold completely different attitudes regarding this treatment. Age above 50 and female physicians generally had a more positive attitude towards the use of MC. Guidelines and clear recommendations are needed.